Reimbursement Risks Driving Contingency-Based Deals, GSK Exec Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Industry executives address the rise of back-end loaded deals during the Bio Windhover Pharmaceutical Strategic Outlook conference Feb. 24.